Dana Urban-Thropp
Physician Assistant · Atlanta, GANPI 1386276426
Payments from drug & device makers
Across 235 payments — averaging $21.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$924
- Viiv Healthcare Company$855
- Merck$487
- La Jolla Pharmaceutical Company$387
- Johnson & Johnson$351
- Astellas Pharma US Inc$333
- plus $2K from 18 others
What the payments were for
- Food & beverage$4,94799%
- Education$451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 37 | $924 |
| Viiv Healthcare Company | 47 | $855 |
| Merck | 20 | $487 |
| La Jolla Pharmaceutical Company | 18 | $387 |
| Johnson & Johnson | 21 | $351 |
| Astellas Pharma US Inc | 12 | $333 |
| AbbVie | 13 | $298 |
| Paratek Pharmaceuticals, Inc. | 15 | $294 |
| Theratechnologies Inc. | 14 | $261 |
| Shionogi Inc | 6 | $167 |
| Melinta Therapeutics, LLC | 5 | $142 |
| Cumberland Pharmaceuticals, Inc. | 7 | $134 |
| Napo Pharmaceuticals Inc | 4 | $71 |
| Pfizer | 3 | $61 |
| Hologic Sales And Service, LLC | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Janssen Scientific Affairs, LLC | 2 | $34 |
| Mayne Pharma Commercial LLC | 2 | $30 |
| VBI Vaccine (delaware) Inc. | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| CSL Behring | 1 | $14 |
| EMD Serono, Inc. | 1 | $14 |
| Hydrofera LLC | 1 | $13 |
How this compares
$4,992 in reported general payments places this provider in the 90th percentile of 3,581 physician assistant providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 67 | $309,558 |
| DescovyEmtricitabine/Tenofov Alafenam | 41 | $91,780 |
| TivicayDolutegravir Sodium | 30 | $69,378 |
| JulucaDolutegravir/Rilpivirine | 16 | $69,336 |
| PrezcobixDarunavir/Cobicistat | 22 | $61,064 |
| PifeltroDoravirine | 11 | $21,952 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy | $924 | $401,337108 claims |
| Viiv Healthcare CompanyTivicay, Juluca | $855 | $138,71546 claims |
| Johnson & JohnsonPrezcobix | $351 | $61,06422 claims |
| MerckPifeltro | $487 | $21,95211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,581 physician assistant providers in Georgia.
Other physician assistant in Atlanta
- Jennifer CobbsAtlanta$1M
- Alison MoeAtlanta$410K
- Maggie SchreckAtlanta$389K
- Jaime AckermanAtlanta$84K
- Andrew GoodnerAtlanta$56K
- Tiffany LangemanAtlanta$53K
- Amy SimoneAtlanta$51K
- Rachel NeelyAtlanta$44K
- Jennifer YoungAtlanta$32K
- Kia CampbellAtlanta$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.